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A Cdc42 target protein with homology to the non-kinase domain
of FER has a potential role in regulating the actin cytoskeleton
Pontus Aspenström
Background: Members of the Rho family of small GTPases have been shown
to have a diverse role in cell signalling events. They were originally identified as
proteins that, by regulating the assembly of the actin cytoskeleton, are important
determinants of cell morphology, and have recently been shown to be involved
in transcriptional activation by the JNK/SAPK signalling pathway. In order to
understand the mechanisms underlying the effects of Rho GTPases on these
processes, the yeast two-hybrid system has been used to identify proteins that
bind to an activated mutant of Cdc42, a Rho-family member.
Results: A cDNA encoding a previously unidentified Cdc42 target protein,
CIP4, which is 545 amino-acids long and contains an SH3 domain at its
carboxyl terminus, was cloned from a human B-cell library. The amino terminus
of CIP4 bears resemblance to the non-kinase domain of the FER and Fes/Fps
family of tyrosine kinases. In addition, similarities to a number of proteins with
roles in regulating the actin cytoskeleton were noticed. CIP4 binds to activated
Cdc42 in vitro and in vivo and overexpression of CIP4 in Swiss 3T3 fibroblasts
reduces the amount of stress fibres in these cells. Moreover, coexpression of
activated Cdc42 and CIP4 leads to clustering of CIP4 to a large number of foci
at the dorsal side of the cells.
Conclusions: CIP4 is a downstream target of activated GTP-bound Cdc42,
and is similar in sequence to proteins involved in signalling and cytoskeletal
control. Together, these findings suggest that CIP4 may act as a link between
Cdc42 signalling and regulation of the actin cytoskeleton.
Background
The actin filament system is an important determinant for
the morphological heterogeneity and motile behaviour of
eukaryotic cells [1,2]. There is a close correlation between
transmembrane signalling events and the mobilisation of
the actin filament system. This correlation can be visu-
alised by treating cells in tissue culture with growth
factors, such as platelet-derived growth factor (PDGF) or
epidermal growth factor: the immediate response is an
accumulation of polymerised actin at the cell periphery, a
phenomenon known as membrane ruffling [3,4]. The
highly dynamic organisation of the actin filament system
is indispensable for the capability of cells to respond to
changes in the external environment. Members of the Rho
family of small GTPases have recently emerged as potent
regulators of the actin filament system, linking
ligand–receptor interactions to the assembly of actin-con-
taining subcellular compartments [5]. There are at least
six distinct members of the Rho GTPases: Rho (isoforms
A, B and C), Rac (isoforms 1 and 2), Cdc42 (Cdc42Hs and
G25K isoforms), RhoG, RhoE and TC10 [5,6]. They are
closely related to the proto-oncogene product Ras, with
which they share the ability to bind and hydrolyse GTP.
These small GTPases are activated when in the GTP-
bound conformation and the hydrolysis of the bound GTP
inactivates the proteins. The cycling between active and
inactive conformations enables the Rho GTPases to func-
tion as binary switches. Furthermore, this cycling is gov-
erned by a large number of proteins that either activate
the Rho proteins by facilitating GDP/GTP exchange —
the so-called guanine nucleotide exchange factors (GEFs)
[7] — or inactivate them by increasing their rate of intrin-
sic GTP hydrolysis [8]. This latter group of proteins are
called GTPase activating proteins, or GAPs.
Most of the initial information about the regulatory role of
the Rho GTPases on the actin filament system came from
studies on Swiss 3T3 fibroblasts. It was shown that Rac reg-
ulates the membrane ruffling activity that occurs at the cell
edge [9], whereas Rho appears to have a specific role in
controlling the assembly of focal contacts [10]. Cdc42, on
the other hand, was originally found in the budding yeast
Saccharomyces cerevisiae, in which it was characterised as a
gene involved in the cell division cycle [11]. In S. cerevisiae,
the activity of Cdc42 is needed for correct assembly of
protein components, including actin, at the site of the bud.
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In fibroblasts, microinjection of activated Cdc42 triggers
formation of filopodia or microspikes at the cell periphery
[12,13]. Moreover, recent studies have demonstrated that
the Rho GTPases also participate in transcriptional regula-
tion. Cdc42 and Rac are able to induce a cascade of sequen-
tial phosphorylations that eventually leads to activation of
the Jun N-terminal kinase/stress-activated protein kinase
(JNK/SAPK) [14–17]. Cdc42 and Rac also have a role in
cell-cycle control, as they are needed for progression
through G1 [17]. In contrast to Ras, the Rho GTPases show
very weak transforming activity; however, Rac and Rho
appear to be important for maintenance of the transformed
phenotype of cells transformed with Ras or Raf [18–20].
A lot of effort has been put into the search for proteins that
bind to activated Rac and Cdc42 in order to understand the
mechanisms underlying their effects on actin assembly and
JNK/SAPK activation. Several proteins that are recognised
by the activated, GTP-bound forms have been found: these
include the Ser/Thr protein kinases PAK [21] and the SH3-
domain-containing proline-rich protein kinase (SPRK),
which is also known as mixed lineage kinase 3 (MLK3)
[22,23], the non-receptor tyrosine kinase p120ACK [24] and
the Wiskott–Aldrich syndrome protein (WASP) [25–27].
Database analysis has shown that these proteins contain a
common Cdc42/Rac-binding motif, the so-called CRIB
motif, which is present in a number of other proteins from
different organisms [28]. Cdc42 and Rac also bind to the
RasGAP-related protein IQGAP1 [29], and they have also
been implicated in the activation of the p70S6 kinase, which
leads to transcriptional activation in a pathway distinct from
the JNK/SAPK signalling pathway [30]. 
It is not clear how Cdc42 and Rac can induce such appar-
ently distinct cellular responses as reorganising the actin
cytoskeleton and activating JNK/SAPK-controlled tran-
scription. A clue has recently come, however, from studies
using Cdc42 and Rac harbouring mutations in their effec-
tor loops. This domain of the protein is involved in the
interaction of the GTPase with its effector proteins, and
the binding can be modulated by the introduction of point
mutations. Cdc42 and Rac harbouring Tyr40→Cys amino-
acid substitutions no longer bind PAK or WASP, and the
mutant proteins are unable to activate the JNK/SAPK sig-
nalling pathway; however, they are still able to induce
cytoskeletal reorganisation [31,32]. Rac containing a
Phe37→Ala or Phe37→Leu mutation is not able to induce
lamellipodia, whereas binding to PAK and activation of
JNK/SAPK are unaffected [31,32]. These findings suggest
that Cdc42 and Rac control the JNK/SAPK pathway and
the assembly of the actin cytoskeleton through distinct
downstream targets.
I have used the yeast two-hybrid system to isolate proteins
that bind specifically to the active GTP-bound conforma-
tion of Cdc42. In this screen, using an Epstein–Barr virus
(EBV)-transformed B-cell library, five potential Cdc42-
interacting proteins (designated CIP1–CIP5) were isolated.
We have previously identified one of these as WASP [25].
Here, the isolation of another one, CIP4, which encodes a
545 amino-acid residue protein with a possible role in the
regulation of the actin cytoskeleton, is described.
Results
Isolation of CIP4
The yeast two-hybrid system was used to isolate cDNAs
encoding proteins that bind to a constitutively activated
mutant of Cdc42 (L61Cdc42), containing a Gln61→Leu
substitution. Using this screen, 19 clones were identified
that retained the positive signal when reintroduced into
yeast cells expressing a fusion protein of the GAL4 DNA-
binding domain (GAL4DB) and L61Cdc42. These cDNAs
encoded five different proteins, which were designated
Cdc42-interacting protein (CIP) 1–5. Database searches
showed that CIP1 was identical to WASP, an observation
which has been described elsewhere [25]. CIP2 turned out
to be identical to 14-3-3b, a protein implicated in the acti-
vation of the c-Raf protein kinase and in protein kinase C
(PKC) signalling [33]. However, an interaction between
Cdc42 and 14-3-3b could not be detected in in vitro
binding assays (P.A., unpublished observations), thus the
biological significance of this interaction remains to be vali-
dated. The single copy of the clone encoding CIP3 was a
partial cDNA of the SPRK/MLK3 gene [22,23]. CIP4 and
CIP5 are previously unidentified proteins, although a
human cDNA of 620 basepairs (bp) that exactly matched
nucleotides 1370–1952 of the CIP4 gene was found in the
database. This partial clone contained an additional 37 bp
at the 5′ end that did not match CIP4 but represented
mitochondrial DNA [34].
The longest CIP4 clone isolated was 2 kb and sequence
analysis strongly suggested that it encodes the full-length
CIP4 protein as the putative initiator codon is preceded by
the hexamer sequence AGCAGC, which is in agreement
with the consensus for initiation of transcription [35]. The
CIP4 open reading frame encodes a protein of 545 amino
acids with a calculated molecular mass of 63 kDa and an
estimated pI of 5.2 (see Supplementary material).
Domain structure of CIP4 
Analysis of the primary structure of CIP4 showed that it
contained an SH3 domain at the extreme carboxyl termi-
nus, and database searches revealed the presence of
related proteins in several organisms: YHR4 in S. cerevisiae,
YA65 in Schizosaccharomyces pombe and Cm19c6 in
Caenorhabditis elegans (Figure 1). In addition, a partial,
carboxy-terminal sequence of a mouse protein, FBP17,
has about 50% identity to the corresponding region of
CIP4. FBP17 has been shown to bind to a proline-rich
peptide derived from formin, which is a protein implicated
in the development of limbs [36]. Like CIP4, FBP17 and
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Cm19c6 contain carboxy-terminal SH3 domains, whereas
YHR4 and YA65 each contains two such domains in
tandem. The SH3 domain of CIP4 most closely resembles
the one in FBP17 (67% identity) and to a lesser extent the
one in Cm19c6 (52% identity) and the first of the two in
YA65 and YHR4 (42% and 33% identity, respectively); its
identity to the SH3 domains of Abl2, Src and Fyn is
approximately 30% (see Supplementary material). Fur-
thermore, the first 300 amino acids of CIP4 show similar-
ity to the non-catalytic amino termini of the non-receptor
tyrosine kinase FER and the Fujinami Sarcoma virus
Fes/Fps family of proto-oncogene products [37,38]. The
part of CIP4 with the highest degree of similarity to other
protein domains is the region between amino acids 132
and 294 (see supplementary material).
Further computer analysis suggested the presence of pre-
viously unidentified domain structure at the extreme
amino terminus of CIP4, amino acids 1–56 (see supple-
mentary material). This motif, which we have chosen to
call FER–CIP4 homology (FCH) domain, is present in
FER and CIP4 as well as in a number of proteins through-
out the phylogenetic tree, most notably the RhoGAP
protein p115 [39], the actin-organising protein Cdc15 from
S. pombe [40], the mouse proteins h74 and growth-arrest-
specific gene product. In addition, this domain is present
in two gene products from C. elegans (F09E10.9 and
F45E1.7) and one from S. cerevisiae (YM9973.05). Nothing
is known about the function of these latter proteins.
In contrast to the other CIP4-like proteins shown in
Figure 1, CIP4 shows some similarity to moesin and to
other members of the ezrin/radixin/moesin (ERM) family
of actin-binding proteins [41]. The overall identity
between CIP4 and moesin is relatively low, around 17%,
but the degree of homology is more pronounced, around
30% identity, between a fragment encompassing amino
acids 329–410 of CIP4 and an analogous domain of moesin
and the other ERM proteins (see Supplementary mater-
ial). This domain overlaps with the Cdc42-binding domain
of CIP4, amino acids 293–481.
Tissue distribution of CIP4
Northern blot analysis demonstrated that a major CIP4
transcript of 2.2 kb was abundant in skeletal muscle, heart
and placenta (Figure 2). Lower levels of transcript were
present in pancreas, lung, liver and kidney, and there was
almost none at all in brain. The transcript size of 2.2 kb
correlates well with the isolated 2 kb CIP4 cDNA and
further supports the notion that the isolated clone is close
to full length. In addition, weak bands of 3.5 and 5 kb
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Figure 1
Proteins with homology to CIP4 are shown, with the Fer–CIP4
homology (FCH) domains (light grey), FER-homologous domains (light
blue), tyrosine kinase domains (dark grey), SH2 domains (dark blue)
and SH3 domains (black) indicated.
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Figure 2
Tissue distribution of CIP4. Northern blot analysis of mRNA from the
human tissues indicated.
CIP4
9.5
kb
7.5
4.4
2.4
1.35
He
art
Br
ain
Pla
ce
nta
Lu
ng
Liv
er
Sk
ele
tal
 m
us
cle
Kid
ne
y
Pa
nc
rea
s
were visible, which most probably represent alternatively
spliced variants of CIP4.
Binding of GTPases to CIP4 in the yeast two-hybrid system
The binding of full length CIP4 (CIP41–545) to L61Cdc42
was analysed by reintroducing a fusion of CIP41–545 and
the GAL4 activation domain (GAL4AD) in the pACT
vector into yeast cells expressing GAL4DB–L61Cdc42,
after which the cells were spread on medium lacking histi-
dine, as described in Materials and methods. The transfor-
mants were then patched onto new plates with medium
lacking histidine. Under these conditions, cells grow only
in those cases where an interaction between the two
fusion proteins restores a functional GAL4 protein and
thereby induces transcription of the reporter genes.
Figure 3a shows that GAL4AD–CIP41–545 interacts with
GAL4DB–L61Cdc42 but not with GAL4DB fused to a
dominant-negative Cdc42 mutant that is constitutively in
the GDP-bound form (N17Cdc42). GAL4AD–RhoGAP,
which is known to bind to GAL4DB fused to Rho and Rac
activated mutants containing leucine at positions 63 and
61, respectively (L63Rho and L61Rac) as well as to
GAL4DB–L61Cdc42 in this system [42], was included as
a control (Figure 3a). GAL4AD–CIP41–545 did not bind to
any other GAL4DB–GTPase tested (Figure 3b). In addi-
tion, the plates were analysed for lacZ activity using a
membrane transfer assay and X-gal as a substrate [42]
(data not shown).
The strength of the interaction between GAL4AD–
CIP41–545 and GAL4DB–L61Cdc42 was determined using
a solution assay in which cells were lysed and the b-galac-
tosidase activity determined spectrophotometrically by
using o-nitrophenyl-b-D-galactopyranoside (ONPG) as a
substrate. The b-galactosidase activity in yeast trans-
formed with both CIP4 and L61Cdc42 fusion proteins was
59 units, which was more than 10 times the activity esti-
mated for yeast transformed with both RhoGAP and
L61Cdc42 fusion proteins [Table 1]. 
In vitro binding analysis
In order to analyse the binding of CIP4 to Cdc42 in vitro,
amino acids 293–481 of CIP were produced as a
glutathione-S transferase (GST) fusion protein (GST–
CIP4293–481) in Escherichia coli. This fragment was selected
because CIP4 lacking residues 1–292 was still able to bind
to Cdc42 in the yeast two-hybrid system (data not shown)
and to exclude the SH3 domain, which is unlikely to bind
directly to Cdc42. The expression level of
GST–CIP4293–481 was relatively high; however, the protein
appeared as a doublet when analysed by gel electrophore-
sis, presumably due to partial degradation (Figure 4). The
interaction between CIP4 and Rho GTPases was analysed
using a dot-blot assay, in which GST–CIP4293–481 protein
was spotted onto nitrocellulose filters and overlaid with
Rho GTPases preloaded with [32P]GTP.
GST–CIP4293–481 bound equally well to L61Cdc42 and to
another mutant of Cdc42 (V12Cdc42; which contains a
valine at position 12), and with a slightly weaker apparent
affinity to wild-type Cdc42 (Figure 5a). CIP4 did not bind
at all to L61Rac, whereas the interaction with L63Rho
was of the same apparent strength as the one with
L61Cdc42 (Figure 5a). After washing the filters with
buffer containing 0.5 M NaCl, however, CIP4 no longer
bound to L63Rho, whereas its interaction with L61Cdc42
remained strong (Figure 5b).
The GTP dependence of the interaction between Cdc42
and CIP4 was analysed using a bead assay in which
GST–CIP4293–481 was incubated with L61Cdc42 preloaded
with either [3H]GTP or [3H]GDP. Glutathione–Sepharose
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Table 1
Interaction between GAL4BD–L61Cdc42 and GAL4AD fusion
proteins in the yeast two-hybrid system.
GAL4DB fusion GAL4AD fusion b-galactosidase 
activity (U)
L61Cdc42 RhoGAP 4.9 (± 0.6)
L61Cdc42 CIP4 59.2 (± 5.1)
– CIP4 0.2 (± 0.1)
Vectors encoding CIP4 and RhoGAP GAL4AD fusion proteins were
transformed into Y190 cells expressing GAL4DB–L61Cdc42 or
GAL4–DB alone. The transformed yeast cells were plated onto selective
media lacking histidine and supplemented with 25 mM 3-aminotriazole.
Three colonies from each transformation were isolated and cultivated
overnight in selective medium. The cells were collected and
permeabilised, after which the b-galactosidase activity was measured
using ONPG as a substrate. The results represent the means of
duplicate samples from each of the three independent transformations.
Figure 3
Interaction of Cdc42 with CIP4 in the yeast
two-hybrid system. Four independent colonies
were patched onto selective medium as
described in Materials and methods and
analysed for growth. (a) The interaction
between GAL4DB–L61Cdc42 and the
indicated GAL4AD fusion proteins. (b) The
ability of GAL4AD–CIP4 to interact with the
indicated GAL4DB fusion proteins.
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beads were then added to the samples and the radioactivity
remaining bound to the beads after washing was deter-
mined by collecting the samples onto nitrocellulose filters
and counting them in a scintillation counter. About 5% of
the added [3H]GTP⋅L61Cdc42 remained bound to GST-
CIP293-481, which was well above the background estimated
using free GST as a control (Figure 6). Under similar condi-
tions, 11% of the added radioactivity remained bound to
GST–RhoGAP. No binding of GST–CIP4293–481 to
[3H]GDP⋅L61Cdc42 was detected. The interaction
between GST–CIP4293–481 and L63Rho was not strong
enough to be detected in this type of assay (data not
shown). In addition, the ability of CIP4 to increase the
intrinsic GTPase activity of Cdc42 was determined by incu-
bating GST–CIP4293–481 with wild-type Cdc42 which had
been preloaded with [32P]GTP. No effect of the CIP4 frag-
ment on the hydrolysis activity of Cdc42 could be detected
(data not shown).
Intracellular localisation of CIP4
Swiss 3T3 fibroblasts were seeded on coverslips and tran-
siently transfected with haemagluttinin-tagged CIP4
(HA–CIP4) and the proteins’ subcellular localisation was
detected using an anti-HA antibody (Figure 7). HA–CIP4
appeared to be present throughout the cell body, particu-
larly in cells expressing high levels of the protein. An
accumulation of HA–CIP4 protein was often found at the
cell periphery, particularly in areas that exhibited mem-
brane ruffling (Figure 7a,c). In addition, the edges of the
cells expressing HA–CIP4 had a more undulated appear-
ance than cells in the same sample expressing background
levels of CIP4 (Figure 7a,c). Expression of HA–CIP4 cor-
related with a decrease in the general tetramethylrho-
damine isothiocyanate (TRITC)-phalloidin staining and
with a decrease in stress-fibre content, suggesting that
CIP4 either caused breakdown of the pre-existing stress-
fibres or interfered with their formation (Figure 7b,d).
The inhibitory role of CIP4 was also tested in transfected
cells that had been serum-starved for 12 hours and then
stimulated by the addition of 10% fetal calf serum (FCS)
before fixation. This procedure effectively triggered the
formation of stress fibres in control cells; however, the
stress-fibre content was reduced in HA–CIP4-expressing
cells and the actin filaments still visible appeared thinner
and less organised than in the cells expressing background
levels of CIP4 (Figure 7e,f). In addition, a reduction of the
stress-fibre content was detected in HA–CIP4-expressing
cells stimulated with either the B-chain of PDGF (PDGF-
BB; Figure 7g,h) or bradykinin (Figure 7i,j).
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Figure 4
Gel electrophoretic analysis of GST–CIP4293–481 (lane 2) run
alongside molecular weight markers (lane 1).
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Figure 5
Interaction of GST–CIP4293–481 with Cdc42, Rac and Rho in the dot-
blot assay. GST fusion proteins were spotted onto nitrocellulose filters
and incubated in the presence of GTPases preloaded with [32P]GTP
and the filters were visualised after either (a) normal washing or (b) a
further wash in buffer containing 0.5 M NaCl.
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Figure 6
GTP-dependence of the interaction between Cdc42 and CIP4
determined using the glutathione–Sepharose bead assay. Results are
the mean of four separate experiments measuring the binding of GST,
GST–RhoGAP230–439 and GST–CIP293–481 to [3H]GTP⋅L61Cdc42
and [3H]GDP⋅L61Cdc42.
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Cotransfection of L61Cdc42 with HA–CIP4 caused a
clustering of HA–CIP4 into a large number of brightly
shining dots which were found to be predominantly on
the dorsal side of the cells (Figure 8a,b). These dots
appeared to co-localise with Cdc42 (Figure 8c,d);
however, such a distribution of Cdc42 was not detected in
cells expressing only L61Cdc42, in which the staining
appeared uniform (Figure 8g,h). Surprisingly, a similar
spotted organisation of CIP4 protein was also visible in
cells expressing both N17Cdc42 and HA–CIP4
(Figure 8e,f). The reason for this is unclear, but it sug-
gests that the clustering of CIP4 is dependent on factors
other than the direct interaction between Cdc42 and
CIP4. This is further emphasised by the fact that CIP4
clustering can be induced by L61Rac (Figure 8k,l), or by
stimulation of cells transfected with HA–CIP4 either with
PDGF-BB (Figure 7g,h) or with bradykinin (Figure 7i,j),
suggesting that both Cdc42 and Rac regulated pathways
are needed to trigger CIP4 clustering.
Discussion
Data from Swiss 3T3 fibroblasts has demonstrated that
Cdc42 is of particular importance for the formation of pro-
trusions at the cell periphery, known as microspikes or
filopodia. These protrusions are composed of tightly
packed bundles of actin filaments which are organised with
their fast growing, or barbed, ends towards the cell edge
[43]. The formation of microspikes precedes the formation
of lamellipodia or membrane ruffles and their increased
activity usually correlates with an increased motile activity
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Figure 7
Subcellular localisation of HA–CIP4 in Swiss 3T3 fibroblasts transfected
with pJ3H–CIP4. (a,b) Cells were left for 48 h without removal of serum
before fixation and detection of either (a) HA–CIP or (b) filamentous
actin, as described in Materials and methods. For other treatments, cells
were either (c,d) serum-starved for 12 h, or serum-starved and then
stimulated with either (e,f) 10% FCS for 30 min, (g,h) 100 ng PDGF-BB
for 15 min, or (i,j) 100 ng bradykinin for 1 h before fixation and detection
of either (c,e,g,i) HA–CIP4 or (d,f,h,j) filamentous actin.
Figure 8
Subcellular localisation of HA–CIP4 in Swiss 3T3 cells cotransfected
with pJ3H–CIP4 and vectors directing expression of (a–d) myc-tagged
L61Cdc42, (e,f) myc-tagged N17Cdc42, (k,l) myc-tagged L61Rac, or
(m,n) myc-tagged L63Rho. Cells transfected with vectors directing
expression of either (g,h) myc-tagged L61Cdc42 or (i,j) myc-tagged
N17Cdc42 alone are also shown. HA–CIP4 was detected using an
anti-HA antibody and either (a,e,k,m) FITC-conjugated or (c) TRITC-
conjugated anti-mouse antibodies. Myc-tagged Cdc42 was detected
using either (g,i) anti-myc or (d) anti-Cdc42 antibodies followed by
FITC-conjugated anti-mouse and anti-rabbit antibodies, respectively.
Filamentous actin was detected using TRITC-conjugated phalloidin.
of the cells [1,2]. Microinjection of the constitutively active
Cdc42 mutant, V12Cdc42, into Swiss 3T3 cells effectively
triggers the formation of filopodia [12]. Furthermore, treat-
ment of cells with bradykinin induces a similar response,
an effect which can be blocked by introducing the domi-
nant-negative N17Cdc42 mutant protein into the cells
[13]. This suggests that seven transmembrane domain G-
coupled receptors can act upstream of Cdc42 in a pathway
that eventually leads to the formation of filopodia. 
The isolation and characterisation of proteins that are
recognised by activated Cdc42 have not yet increased the
understanding of the mechanisms underlying the effect of
Cdc42 on the actin cytoskeleton. The function of the
SH3-domain-containing tyrosine kinase p120ACK is largely
unknown [24], whereas the Ser/Thr kinases PAK and
SPRK/MLK3 appear to be components of the signalling
cascade that eventually leads to JNK activation [44–47].
Work using effector mutants of Cdc42 and Rac has shown
that the downstream pathways bifurcate at the level of
Cdc42 and Rac, and that the activation of JNK and
cytoskeleton rearrangements appear to be regulated by
distinct pathways [31,32]. These reports suggest that the
proteins containing the CRIB (Cdc42/Rac-interactive
binding) motif are not responsible for the organisation of
the actin cytoskeleton, but some data suggest that PAK1
could still promote cytoskeletal rearrangements via a
pathway that requires the adaptor protein Nck [48].
CIP4 represents a novel class of potential Cdc42 effector
proteins; members of this class lack a CRIB motif and at
least CIP4 appears to have an effect on the organisation of
the actin cytoskeleton. Swiss 3T3 cells transfected with
HA–CIP4 had a more rounded or undulated appearance
than control cells, which suggests that they have elevated
membrane ruffling activity. The CIP4 protein seems, at
least to an extent, to be accumulated in those areas at the
periphery of the cells that ruffle. It is, however, unlikely
that CIP4 binds directly to actin as it does not appear to
contain regions with homology to known actin-binding
domains. Instead, an inhibitory effect of CIP4 on stress-
fibre formation might occur by CIP4 activating actin
depolymerising factors that could disassemble pre-existing
filaments. Alternatively, CIP4 might bring about seques-
tration of actin monomers leading to a local increase in the
pool of unpolymerised actin. It remains to be established
which of these two possible mechanisms is effective here.
Proteins related to CIP4 have so far been found in mouse
(FBP17), S. pombe, S. cerevisiae and C. elegans. These pro-
teins are likely to share several features; however, whether
these features include the Cdc42-binding motif that is pre-
sumably present in CIP4 remains to be investigated. The
identity between CIP4 and FBP17 is about 50%, which
makes it unlikely that FBP17 is the mouse homologue of
CIP4. It is therefore likely that there are at least two
isoforms of CIP4 in mammalian cells. FBP17 was cloned
from an expression library as a protein that could bind to a
proline-rich peptide derived from formin. Formins are pro-
teins with a role in mouse development and, in particular,
limb formation [36]. The proline-rich peptide used in the
study bound to several proteins containing either SH3
domains or WWP/WW domains. Interestingly, an observa-
tion that also suggests that Rho proteins can have a role in
the development of limbs comes from a study of the
product of the fasciogenital dysplasia gene (FGD1), a
Cdc42 exchange factor. This gene is absent or mutated in
the developmental disorder Aarskog–Scott syndrome and
patients with this rare disorder suffer from characteristic
facial, skeletal and urogenital anomalies [49,50]. It is thus
tempting to speculate that Cdc42, via downstream target
proteins like CIP4, is involved in signalling events leading
to correct development of the limbs.
The primary sequences of the first 300 amino acids of
CIP4-related proteins show homology to a similar domain
in FER and Fes/Fps. The amino-terminal 60 amino acids
appears to contain a domain structure present in all CIP4-
related proteins with the exception of Cm19c6. This
domain was subsequently found in a number of proteins,
and I propose that it is named the FER–CIP4 homology
(FCH) domain. Several of the FCH-domain-containing
proteins have potential roles in organising Rho proteins
and the actin cytoskeleton. The X-chromosome-linked
gene product, p115, contains a RhoGAP domain and has
an inhibitory effect on stress-fibre organisation [39]. Cdc15
is an S. pombe gene involved in mediating the actin fila-
ment reorganisation required for cytokinesis [40]. Previous
studies have implicated the noncatalytic amino-terminal
domain of Fes/Fps in activating the protein by translocat-
ing it to the plasma membrane [38]. The target molecules
responsible for this translocation have not been charac-
terised so far. It is a possibility that the amino termini of
the CIP4-related proteins can bind to related target mol-
ecules via their FCH domains.
The members of the ERM family of protein have been
shown to co-localise with actin filaments and to bind actin
[51,52]. Moesin and ezrin are present at the apical
microvilli of epithelial cells and ezrin has been suggested
to be involved in the assembly of the microvilli in the
intestinal brush border [53]. The region of homology
between CIP4 and the ERM proteins is outside the actin-
binding domain, which makes it unlikely that CIP4 binds
directly to actin molecules. The overall similarity between
them suggests, however, that CIP4 and moesin participate
in similar signalling pathways.
Conclusions
It is concluded that CIP4 is a downstream target of
activated Cdc42 in vitro as well as in vivo. Cdc42 has a spe-
cific effect on fibroblasts in tissue culture — it induces the
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formation of filopodia at the periphery of cells. This process
is likely to be complex and the work on Cdc42 effector pro-
teins has not yet been able to explain how the transfer of
information from activated Cdc42 to the actin cytoskeleton
to form filopodia is achieved. None of the Cdc42 effector
proteins isolated so far has been able to induce the forma-
tion of filopodia on their own. Overexpression of WASP in
pig endothelial cells and NRK epithelial cells causes an
accumulation of polymerised actin into large conglomerates
at the perinuclear area [26]. Overexpression of CIP4 has a
different effect on the organisation of the actin cytoskele-
ton — it causes a reduction in the stress-fibre content. The
clustering of CIP4 into a large number of foci, triggered by
a simultaneous overexpression of Cdc42 or Rac, or by treat-
ment with PDGF-BB or bradykinin, might be needed for
the initial stage in the formation of a filopodium.
Materials and methods
Yeast two-hybrid screen
The yeast strain and library used in the screen have been described previ-
ously [25]. Analysis of the three cDNAs encoding CIP4 showed that it had
not been previously identified and that one of the clones encoded the full-
length 545 amino-acid protein. The two additional cDNAs encoded amino-
acid residues 112–545 and 293–545 of CIP4. The carboxy-terminal
amino-acids encoding the GAP domain of RhoGAP (230–439) were sub-
cloned into pACTII. L61Rac, N17Rac (Rac1 isoform), L63Rho, N19Rho
(RhoA isoform) and L87R-Ras were introduced into pYTH6 and trans-
formed into Y190 as described [25,42]. The ability of the
GAL4DB–GTPases to bind to GAL4AD–CIP4 and GAL4AD–RhoGAP
was analysed by transforming pACT–CIP41–545 and pACTII into Y190
cells expressing the various GALDB–GTPase constructs. The cells were
grown on medium lacking histidine containing 25 mM 3-aminotriazole, as
described previously [25,42]. The b-galactosidase production from the
LacZ reporter gene was analysed using a membrane transfer assay or the
solution assay as described before [42].
DNA work, sequencing and northern blot analysis
The DNA work followed standard procedures [54]. The nucleotide
sequence of pACTCIP41-545 was determined by the method of Sanger
[54] or using a Perkin Elmer Genetic Analyzer 310. Nested oligonu-
cleotide primers were used to perform double-stranded sequencing and
both strands of CIP4 were each sequenced at least three times. The
nucleotide sequence and the translated amino-acid sequence were
analysed for homology to known proteins using the FASTA or BLAST
functions in the Genetic Computer Group (GCG) package or via internet
on GeneBank. For northern blot analysis, a hybridisation-ready northern
blot (Human Multiple Tissue Northern Blot; Clonetech) containing mRNA
from heart, brain, placenta, lung, liver, skeletal muscle, kidney and pan-
creas was hybridised using a probe (consisting of nucleotides 817–2000
of CIP4 labelled with [32P]CTP) according to the manufacturer’s instruc-
tions (rediprime, Amersham).
Protein production, dot-blot assay and glutathione–Sepharose
binding assay
A vector for the production of GST–CIP4293–490 was constructed by gen-
erating an NcoI–HindIII PCR fragment of CIP4 and ligating it into pGEX-
KG (Pharmacia). For production of the protein, pGEX-KG–CIP4293–481
was transformed into BL21 cells and the fusion protein was produced
essentially by following the manufacturer’s protocol, eluted using 5 mM
reduced glutathione and then dialysed overnight at 4°C against 20 mM
Tris-HCl pH 7.5, 50 mM NaCl , 5 mM MgCl2 and 1 mM dithiothreitol (DTT).
GTPases were isolated from GST fusion proteins by thrombin cleavage [8].
For dot-blot assays, GST fusion proteins were spotted onto nitrocellulose
filters and incubated in blocking buffer (5% dried milk, 5% FCS, 1 M
glycine and 1% ovalbumin) for 1 h at room temperature. The filters were
washed twice in buffer A (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM
MgCl2, 1 mM DTT). The filters were then incubated on ice for 10 min in
5 ml buffer A containing 0.1 mM GTP, 1 mg/ml BSA and 0.5 mg GTPase
preloaded with 10 mCi g-[32P]GTP (Amersham, 5000 Ci/mmol). The
filters were washed three times with 0.1 M Tris-HCl pH 8, 0.15 M NaCl,
0.1% Tween 20, wrapped in Saran-wrap and developed on X-ray film
(Hyperfilm-MP, Amersham), for 1 h at –70°C.
For glutathione–Sepharose binding assays, 1 mg L61Cdc42 was pre-
loaded with 2 mCi [3H]GTP or [3H]GDP (7.8 Ci/mmol and 13.3 Ci/mmol,
respectively, Amersham) and incubated with GST–CIP4293–481 or GST
(40 mg of each) for 10 min on ice (the input counts were 110,000 cpm for
[3H]GTP⋅L61Cdc42 and 70,000 cpm for [3H]GDP⋅L61Cdc42). Thereafter,
40 ml glutathione–Sepharose beads (Pharmacia) were added and the
mixture incubated end-over-end for 30 min at 4°C. The beads were washed
3 times with buffer A containing 0.1% Triton X-100, collected on nitrocellu-
lose filters and subjected to scintillation counting.
Cell cultivation, transfection and immunohistochemistry
Swiss 3T3 fibroblasts were cultured in Dulbecco’s modified Eagles’
medium (DMEM) supplemented with 10% FCS and penicillin/streptomycin
and incubated at 37°C in an atmosphere of 10% CO2. The cells were
seeded on coverslips and transfected by the lipofection method using the
LipoFECTAMINE reagent (GIBCO, BRL) following the manufacturer’s pro-
tocol. Plasmids encoding the myc-tagged proteins L63Rho and L61Rac
(generous gifts from N. Lamarche), L61Cdc42 and N17Cdc42, the parental
plasmid pRK5myc (a generous gift from M. Olson), and pJ3H–CIP4 (the
parental plasmid pJ3H was a generous gift from J. Chernoff) were trans-
fected alone or in combinations. After incubation for 48 h, the cells were
harvested and analysed for expression of the introduced cDNAs. 
For immunohistochemistry, the Swiss 3T3 cells were fixed in 2%
paraformaldehyde for 15 min and then permeabilised in 0.2% Triton X-
100 for 15 min. HA–CIP4 was visualised using an anti-HA monoclonal
antibody (12CA5, a generous gift from S. Souchelniskyi) and myc-tagged
Rho GTPases were detected using an anti-myc monoclonal antibody
(9E10, Santa Cruz), followed by incubation for 1 h with fluorescein-isoth-
iocyanate (FITC)-conjugated (Cedarlane Laboratories Ltd) or TRITC-con-
jugated (DAKO) anti-mouse antibodies. Filamantous actin was detected
by incubating the cells with 0.1 mg/ml TRITC-conjugated phalloidin
(Sigma) for 1 h. Cells were photographed using a Zeiss Axiovert 100 flu-
orescence microscope and T-Max 400 films.
Accession numbers
The following gene products are referred to in the text: FBP17 (U40751),
YHR4 (U00059), YA65 (Z54140), Cm19c6 (U41749), h74 (X85124),
YM9973.05 (Z49213), F0910.9 (U41749), growth-arrest-specific gene
product (U19860), Cdc15 (X86179), p115 (X78817), and F45E1.7
(U28732).
Supplementary material available
Figures showing the nucleotide and deduced amino-acid sequences of
CIP4 and the alignment of various regions of CIP4 with homologous
domains of other proteins are published with this paper on the Internet.
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